Hepatitis C Virus Non-Nucleoside NS5B Palm Polymerase Inhibitor
- Name
- Hepatitis C Virus Non-Nucleoside NS5B Palm Polymerase Inhibitor
- Accession Number
- DBCAT003521
- Description
Not Available
- Drugs
Drug Drug Description Dasabuvir A direct-acting antiviral agent used to treat specific hepatitis C virus (HCV) infections in combination with other antiviral agents. - Drugs & Drug Targets
Drug Target Type Dasabuvir Nonstructural protein 5B (NS5B) target Dasabuvir Cytochrome P450 2C8 enzyme Dasabuvir Cytochrome P450 3A4 enzyme Dasabuvir Cytochrome P450 2D6 enzyme Dasabuvir UDP-glucuronosyltransferase 1-1 enzyme Dasabuvir ATP-binding cassette sub-family G member 2 transporter Dasabuvir ATP-binding cassette sub-family B member 5 transporter Dasabuvir P-glycoprotein 1 transporter